Latest Breaking News On - French biotech - Page 1 : comparemela.com

OraSure Technologies, Inc (NASDAQ:OSUR) Q1 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing-by. Welcome to the OraSure Technologies Earnings Conference Call. At this time, participants are in listen-only mode.

United statesWhite houseDistrict of columbiaKen mcgrathScott gleasonFrancis collinsPatrick donnellyRaymond jamesZiwig endotesCasey woodringAndrew cooperAquarius population healthEmory universityPublic health partnersQuest diagnosticsOrasure technologies inc

Jeito Capital co-leads €75 million Series B financing in SparingVision

Jeito Capital co-leads €75 million Series B financing in SparingVision
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFrance generalAssia mouhoutKostenloser wertpapierhandelSabine dandiguianMarion bougeardParis vision instituteRd fundFoundation fighting blindnessUniversity of pittsburgh medical center enterpriseFrench biotechPrivate equityPittsburgh medical center enterpriseYsios capitalJeito capitalIntellia therapeutics

Intellia Therapeutics (NASDAQ:NTLA) – Jeito Capital co-leads €75 million Series B financing in SparingVision - Press Release

- SparingVision is a French Biotech with the ambition of becoming a leader in genomics in ophthalmology. - Jeito Capital was a major investor in the S

United statesFrance generalSabine dandiguianParis vision instituteRd fundFoundation fighting blindnessUniversity of pittsburgh medical center enterpriseFrench biotechJeito capitalPrivate equityPittsburgh medical center enterpriseYsios capitalIntellia therapeuticsManaging partnerInherited retinal diseasesAge macular degeneration

OSE Immunotherapeutics Announces Collaboration with

OSE selected by Microsoft France to join the “Biotech Scaler Program” launched during “Viva Technology”, the European Startup and Tech event.This.

France generalNicolas poirierBio mabsilicoViva technologyNantes university hospitalBiotech scaler programVeloxis pharmaceuticals incBoehringer ingelheimMicrosoft franceEuropean startupArtificial intelligenceFrench biotechChief scientific officerMicrosoft azureNon small cell lung cancerVeloxis pharmaceuticals

OSE Immunotherapeutics Announces Collaboration with Microsoft

OSE Immunotherapeutics Announces Collaboration with Microsoft
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalNicolas poirierBio mabsilicoViva technologyNantes university hospitalBiotech scaler programVeloxis pharmaceuticals incBoehringer ingelheimMicrosoft franceEuropean startupArtificial intelligenceFrench biotechChief scientific officerMicrosoft azureNon small cell lung cancerVeloxis pharmaceuticals